MediVera Compounding Pharmacy

What MediVera Compounding Pharmacy does

MediVera Compounding Pharmacy is a privately held, family-owned 503A compounding pharmacy founded in 1999 and headquartered in Troy, Michigan. The company prepares customized non-sterile and sterile medications for individual patients across eight therapeutic categories: weight management, men's health, women's health, hormone replacement therapy, dermatology, longevity, peptides, and pet medications. Specific formulations include Sermorelin, Glutathione, NAD+, Liraglutide, MIC injections, Trimix (in five strengths), Testosterone Enanthate, and OTC supplements. All compounds are prepared per prescription using ingredients sourced from FDA-registered suppliers, and dispensed directly to patients via direct-to-door shipping with no local pickup option.

MediVera holds dual PCAB accreditation in both sterile and non-sterile compounding, a credential held by fewer than 1% of compounding pharmacies in the United States, and is licensed in 49 states. Operations are based in a 56,000 sq ft purpose-built Troy, MI facility that opened in March 2025, featuring ISO-7 cleanrooms and ISO-5 laminar airflow hoods throughout. The company invests more than $60,000 per month in third-party laboratory testing of every batch, employs nine licensed compounding pharmacists (including a Board Certified Sterile Compounding Pharmacist with 25+ years of experience), and reports USP 795, 797, and 800 compliance. Most compounds ship within 48 hours of prescription verification, and the company reports 94%+ patient satisfaction.

The company serves three customer segments: telehealth companies managing high patient volumes across multiple states (enterprise), independent healthcare providers including private practices and specialty clinics (mid-market), and individual patients (long-tail). Its go-to-market combines enterprise account management with a Provider Portal for e-prescribing and the proprietary Impressed Advantage customer service program, which handles prior authorizations, clinical education, and rapid patient contact. Revenue is generated per prescription filled on a transaction basis; compounded medications are generally not covered by insurance and are typically paid out of pocket. The company is led by CEO Bradley McCloskey and Founder Joe McCloskey, with no disclosed institutional ownership, parent company, or outside funding.

Name

MediVera Compounding Pharmacy

Legal name

MediVera Compounding Pharmacy

Website

https://mediverarx.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

MediVera Compounding Pharmacy is a privately held 503A compounding pharmacy founded in 1999, preparing customized medications across eight therapeutic categories for telehealth companies, independent providers, and patients in 49 states from its Troy, MI facility.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110), Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro industry

PRIMARYHLACAKAM

Compounding Pharmacy & Sterile Prep Workflow Systems

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLACAKAC

Pharmacy Information Systems (PIS) & Dispensing Workflow

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLALALAF

Telepharmacy & Prescription Fulfillment Marketplaces

Healthcare & Life Sciences/Telehealth Platforms/Telehealth Marketplace & Referral Platforms

Keywords

• Compounding pharmacy services
• Sterile medication compounding
• Telehealth prescription fulfillment
• Custom pharmaceutical formulations
• 503A pharmacy operations

Headquarters

HQ city

Troy

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Compounded Medication Dispensing: MediVera generates revenue by compounding and dispensing customized medications based on individual prescriber orders. Every compound is prepared for a specific patient with a valid prescription. The company ships medications directly to patients across 49 states. As a 503A compounding pharmacy, medications are billed at the point of dispensing — most compounds ship within 48 hours of prescription verification. Revenue is transaction-based per prescription filled, with no subscription or recurring billing structure implied.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

MediVera is a 503A compounding pharmacy that prepares and dispenses customized, patient-specific medications across eight therapeutic categories (weight management, men's health, women's health, hormone replacement, dermatology, longevity, peptides, and pet medications) using ingredients sourced from FDA-registered suppliers. The pharmacy ships compounded prescriptions directly to patients across 49 states, most within 48 hours, and supports prescribing providers and telehealth platforms through a Provider Portal, dedicated account management, and its proprietary Impressed Advantage customer service program.

Product overview

MediVera Compounding Pharmacy™ is a PCAB-accredited 503A compounding pharmacy offering customized medications for individual patients. The company operates as a single unified pharmacy service with proprietary programs including the Impressed Advantage customer service model and telehealth fulfillment infrastructure. Core offerings include compounding services across 8 therapeutic categories (weight management, men's health, women's health, hormone replacement, dermatology, longevity, peptides, and pet medications), supported by provider and patient portals. Specific compounded formulations include Sermorelin (nasal spray and injection), Glutathione Injection, NAD+ Injection, Liraglutide Injection, MIC Injection, Trimix (5 strengths), Testosterone Enanthate, and a Deluxe Vacuum Pump Therapy System. All compounds are prepared using ingredients sourced from FDA-registered suppliers and ship within 48 hours to patients across 49 states.

Differentiator

Problem solved

Functional benefit

Brands

• Impressed Advantage: Proprietary customer service program developed by MediVera pharmacists to provide administrative support, provider and patient education, easy prescription submission, and rapid patient contact for practice partnership.
• Impressed Patient Advantage

Products and services

• Compounding Services PCAB-accredited compounding pharmacy providing customized medications for humans and animals across 8 therapeutic categories: weight management, men's health, women's health, hormone replacement, dermatology, longevity, peptides, and pet medications. Each compound is prepared by prescription for the individual patient using ingredients sourced from FDA-registered suppliers.
• Telehealth Fulfillment Prescription fulfillment infrastructure designed for telehealth platforms handling high patient volumes across multiple states. Covers prescription processing, patient communication, and clinical education for telehealth companies seeking a multi-state licensed compounding partner.
• Impressed Advantage Proprietary customer service program covering prior authorization handling, provider and patient education on every compound, easy prescription ordering via fax/phone/eScribe, rapid patient contact (calls answered within 30 seconds), and 94%+ patient satisfaction.
• Provider Portal Online portal for healthcare providers to submit electronic prescriptions via eScribe, manage accounts, and access clinical education resources.
• Quick Refill Patient-facing portal for convenient prescription refills, supported by mobile applications on iOS App Store and Google Play for refill management on the go.
• Sermorelin Compounded GHRH analog peptide available as a 100mcg/0.1mL nasal spray or 0.9mg/mL acetate injection, prescribed to support natural growth hormone production.
• Glutathione Injection Compounded injectable antioxidant formulation prepared for subcutaneous or intramuscular delivery to support oxidative stress reduction and detoxification.
• NAD+ Injection Compounded NAD (nicotinamide adenine dinucleotide) injection prepared for subcutaneous or intramuscular delivery to support cellular energy metabolism and longevity protocols.
• Liraglutide Injection Compounded GLP-1 formulation for weight management protocols.
• MIC Injection Methionine/Inositol/Choline injection for weight management support.
• Trimix Compounded medication combining alprostadil, papaverine, and phentolamine for erectile dysfunction support. Available in five different strengths, with a 50% promotional discount offered on the first trial vial.
• Testosterone Enanthate Compounded testosterone replacement therapy (TRT) formulation in 200mg/ml injection solution for treatment of hypogonadism in adult males.
• Deluxe Vacuum Pump Therapy System Non-invasive therapy system for erectile dysfunction support, offered alongside compounded medications in the men's health category.
• OTC Supplements Over-the-counter supplements offered alongside the compounded medication catalog.

Quantifiable outcome

• 94%+ patient satisfaction rating
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Telehealth PlatformscoreStrategic or Co-development PartnerMediVera has a dedicated telehealth fulfillment division designed to serve telehealth companies managing high patient volumes across multiple states. The partnership covers prescription fulfillment, patient communication, and clinical education. With 49-state licensing and the Impressed Advantage service model, telehealth partners receive consistent, high-quality fulfillment regardless of patient location.
• Independent Healthcare Providers / PrescriberscoreStrategic or Co-development PartnerMediVera partners with private practices, specialty clinics, and high-volume prescribers through its Impressed Advantage program. The partnership model includes dedicated account management, clinical education resources, easy prescription submission via multiple channels (fax, phone, eScribe), and a 48-hour fulfillment standard. The relationship is designed to reduce provider administrative burden and improve patient outcomes.
• FDA-Registered Ingredient SupplierscoreTechnology or IntegrationMediVera sources all active pharmaceutical ingredients exclusively from FDA-registered suppliers, with Certificate of Analysis verification at receipt. This is a foundational quality-control partnership underpinning the company's compounding operations and USP compliance.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Wedgewood Pharmacy: One of the largest compounding pharmacies in the United States, providing customized compounded medications for both human and veterinary patients. Compares to MediVera due to scaled 503A compounding operations, broad therapeutic category coverage, and national direct-to-patient shipping model serving providers and telehealth partners.
• Avella Specialty Pharmacy: National specialty and compounding pharmacy offering customized medications to providers and patients including fertility, hormone, and specialty therapy compounds. Comparable in serving high-volume prescribers and a national patient base with sterile compounding capabilities and clinical education services.

Direct peers

• Stokes Pharmacy: 503A compounding pharmacy specializing in sterile and non-sterile preparations with a focus on provider relationships and patient-specific medications. Compares to MediVera in quality accreditations, customized hormone and wellness formulations, and provider-direct fulfillment workflow.
• College Pharmacy: Long-established compounding pharmacy offering customized sterile and non-sterile preparations. Like MediVera, College Pharmacy has decades of experience, multi-state reach, and serves both individual patients and independent healthcare providers with personalized formulations.
• Empower Pharmacy: Large-scale 503A and 503B compounding pharmacy offering customized medications across wellness, hormone, and weight-loss categories. Like MediVera, Empower ships nationally and serves telehealth platforms and high-volume prescribers, with significant investment in sterile and non-sterile compounding infrastructure.
• US Compounding: 503A compounding pharmacy providing customized preparations and serving as a fulfillment partner for providers and telehealth platforms. Comparable core offering of compounded medications across hormone, weight management, and longevity therapeutic categories, with multi-state licensing.
• Olympia Pharmacy: PCAB-accredited 503A compounding pharmacy offering sterile and non-sterile compounded medications across multiple therapeutic categories. Comparable in tele-health partnership focus, provider portal access, and emphasis on patient-direct ordering across many US states.

Emerging players

• Pet Health Pharmacy: Compounding pharmacy specializing in customized medications for animals. Comparable to MediVera's pet medications offering and veterinary therapeutic category, though narrower in species focus (exclusively animal patients) and scale.
• Townsend Enterprises: PCAB-accredited compounding pharmacy serving providers and patients with customized medications. Adjacent comparison to MediVera in quality standards and provider-partnership orientation, though operating at smaller scale and narrower geographic footprint.

Others

• Letco Medical: Compounding pharmacy supplier and contract manufacturer serving the compounding industry with APIs, equipment, and base ingredients. Indirect peer as an industry supplier enabler for compounding pharmacies like MediVera and a participant in adjacent 503B outsourcing services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mediverarx
• Facebookfacebook.com/mediverarx
• LinkedInlinkedin.com/company/mediverarx
• Instagraminstagram.com/mediverarx

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediVera Compounding Pharmacy